EGRX Quote, Trading Chart, Eagle Pharmaceuticals Inc.
home / stock / egrx / egrx quote
$43.08 Last:
3.04% Change Percent:
$42.48 Open:
$43.08 Previous Close:
$44 High:
$41.41 Low:
170,920 Volume:
03/05/2021 03:15:23 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2021-03-05 | 42.48 | 43.08 | 44 | 41.41 | 170,920 |
| 2021-03-04 | 40.48 | 41.81 | 42.43 | 40.32 | 203,255 |
| 2021-03-03 | 40.54 | 40.32 | 42.17 | 39.895 | 133,795 |
| 2021-03-02 | 43.92 | 40.4 | 44.54 | 40.4 | 185,525 |
| 2021-03-01 | 44.85 | 45.38 | 45.94 | 44.4 | 155,338 |
| 2021-02-26 | 45.75 | 44.5 | 46.45 | 43.8021 | 168,007 |
| 2021-02-25 | 45.56 | 45.78 | 46.57 | 45.46 | 111,716 |
| 2021-02-24 | 45.78 | 45.68 | 46.89 | 45.2601 | 92,621 |
| 2021-02-23 | 45.76 | 45.48 | 46.49 | 44.61 | 104,447 |
| 2021-02-22 | 45.05 | 45.9 | 45.9956 | 44.45 | 142,696 |
| 2021-02-19 | 46.25 | 45.47 | 46.6 | 45.16 | 135,178 |
| 2021-02-18 | 47.36 | 46.29 | 48.14 | 46.06 | 82,823 |
| 2021-02-17 | 45.67 | 47.74 | 48.24 | 45.51 | 87,472 |
| 2021-02-16 | 46.43 | 46.16 | 46.79 | 44.455 | 169,493 |
| 2021-02-15 | 47.77 | 46.35 | 49.225 | 46.13 | 97,167 |
| 2021-02-12 | 47.77 | 46.35 | 49.225 | 46.13 | 97,167 |
| 2021-02-11 | 49.87 | 48.01 | 50.87 | 47.805 | 93,499 |
| 2021-02-10 | 50.25 | 49.96 | 51.355 | 49.7 | 103,759 |
| 2021-02-09 | 50.42 | 49.9 | 51.0625 | 49.27 | 88,121 |
| 2021-02-08 | 49.65 | 50.45 | 50.8 | 49.1 | 96,180 |
Eagle Pharmaceuticals Inc. Company Name:
EGRX Stock Symbol:
NASDAQ Market:
Eagle Pharmaceuticals Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
-
Image source: The Motley Fool. Eagle Pharmaceuticals Inc (NASDAQ: EGRX) Q4 2020 Earnings Call Mar 2, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Eagle Pharmaceuticals Inc (EGRX) Q4 2020 Earnings Call Transcript ...
-
-- Q4 2020 net income was $0.62 per basic and $0.60 per diluted share and adjusted non-GAAP net income was $0.98 per basic and $0.96 per diluted share – -- FY 2020 net income was $0.89 per basic and $0.87 per diluted share and adjusted non-GAAP net income was $3.62 per ba...
-
Eagle Pharmaceuticals, Inc. (“Eagle” or the “Company”) (Nasdaq: EGRX) today announced that the Company will release its 2020 fourth quarter and full year financial results on Tuesday, March 2, 2021, before the market opens. Scott Tarriff, Chief Executive ...